Table of contents
At a glance
What matters when validating pLG WMS for GxP use?
Assess the pLG WMS product line in use against quality-relevant warehouse decisions. Returns must retain tenant, item, batch, quantity and condition. Distinguish recording a return, putting it back into storage, issuing credit and restoring available stock. Supplier features do not establish pharmaceutical release. Include interface failures, retries and incorrect assignments in risk-based tests.
- Do not equate the technical evaluation of pLG WMS, DILOS, and WMS-TM3.
- Physical inventory, quality release decision, and financial booking are separated.
- Check the tenant and batch even when the total quantity is correct.
- Return functions with documented decision authority are binding.
1. Which proLogistik system do you actually use?
proLogistik currently markets pLG WMS as a modular Warehouse Management System with branch-specific adaptations for various industries. The group website also lists systems such as DILOS, LOGIS MOVE, and Logistar. The acquisition of a business unit does not imply a common software foundation. Therefore, "pLG" should not be used as a sufficient technical system designation.
Document the product line, release, and build, modules, interfaces, enhancements, and operating model. The current numerical software version cannot be determined from the publicly available information used herein. The year references 2025 or 12–2024 in brochures pertain to the document status.
For the pharmaceutical distribution sector, the supplier provides specific functionality for pLG WMS-TM3, including ABDA article stock profiles and ADAS/MSV3 integrations. These are not automatically included features of every pLG installation. Similarly, statements regarding cloud-based operation of individual offerings do not constitute a complete service agreement. Please confirm in detail the actual scope of delivery and its limitations.
2. Separate the manufacturer's warehouse and wholesale trade functionally
The central topic of this article concerns a human medicinal product manufacturer that controls backflows monitored in storage. For computerized GMP processes, Annex 11 is the applicable guideline. The current Commission Human Medicinal Product Directive still references the 2011 revision. Customer configuration and intended data usage determine the scope of validation evidence.
For the wholesale sector, the GDP guidelines shall be applied separately. An activity may have multiple interfaces between manufacturing and distribution; responsibilities must align accordingly. Neither a pLG sector designation nor a general warehouse status determines regulatory applicability.
proLogistik describes an audit of the supplier portal Warehouse Logistics conducted by Fraunhofer IML. This is not equivalent to GxP validation of your return process. Request usable delivery notes and verify their coverage. The public statement alone does not demonstrate that your roles, master data, interfaces, or decision criteria have been reviewed.
3. The correct reference point is more than just the article number
The functional overview includes multi-tenant capability, batch numbers, minimum shelf life, serial numbers, and returns. The information that uniquely identifies a booking must be derived from this data for your process. The same article code may appear for two different customers; even the same manufacturer batch does not automatically imply the same owner or the same authorization for use.
The following work matrix ensures that inconsistent statements in a "released" field do not disappear. It serves as an independent planning aid. The specific implementation may involve multiple systems, provided that assignment, responsibility, and impact are demonstrably documented.
| Object or condition | Specific statement | Not equated with | Evidence needed |
|---|---|---|---|
| Client and Owner | For whose inventory is the packaging held? | Same article code or identical batch | Customer assignment in data entry, role, reporting, and ERP message |
| Return item | Which original supply is affected? | Any new goods receipt | Reference, quantity, article/batch and reason for return |
| Physical put-away | Where the packaging is located | Suitability for subsequent supply | Storage location and separately maintained usage status |
| Quality decision | What is permitted regarding the product after evaluation | Inconspicuous photo or closed carton alone | Decision basis, authority, timing, and reference |
| Credit note | Which commercial correction is applied? | Release of goods for a new order | Own booking reference without unintended status impact |
| Order availability | The quantity allowed for this contract | Total physical inventory | Mandant, Batch, Status and relevant date rules |
4. A quality review within the WMS is not an automatic reissue decision.
proLogistik describes a returns process from registration and inspection to return to stock or write-off. It lists integrated quality inspection and classification. For your installation, identify the inspection criteria and who can trigger the next status.
In the GMP manufacturing context, Chapter 5.70 of the re-introduction of products returned to the market imposes strict limitations. Key factors include condition, history, required storage conditions, and elapsed time, as well as a critical evaluation by quality control through written procedures. Where quality concerns arise, the product is not suitable for further release.
For GDP return cases, the internal conditions from Section 6.3 and the responsibilities from Section 2.2 apply. A successful scan or optical incoming inspection does not substitute for this evaluation. Design the return flow dialogue such that missing information remains visible and unintended availability does not occur. A commercially closed transaction may still remain open from a technical or operational standpoint.
5. Verify vendor separation up to the report and to the mobile device
A client selection at the screen is only part of the validation evidence. Verify that users edit the correct inventories and view relevant summaries in a complete and authorized scope. Include mobile data capture, search dialogs, labels, exports, and administrative corrections. Public function lists do not specify these boundaries in detail.
Use deliberate similar test data: the same article code, similar batch numbers, and adjacent storage locations across two customers. The expected error should not be rendered impossible simply due to completely different designations. A meaningful negative test attempts to assign a return to the wrong customer and later use that customer’s order for processing.
The authorized access must be distinguished from change authorization. A central warehouse manager may require overarching information, while a status decision is typically more narrowly scoped. Roles should align with actual responsibilities. Additionally, review standing authorities, exit procedures, and particularly privileged accounts; shared pooled accounts complicate the traceability of user actions.
6. Separate handling of ERP credit posting, inventory notification, and connector
The pLG main page lists standard interfaces to ERP systems such as SAP, Infor, and Microsoft Dynamics. The 3PL brochure highlights inventory and delivery feedback. Additionally, the pLG Supply Chain Connector is offered as a standalone solution for format conversion and data transfer. Its public description mentions, among other things, XML, SAP IDoc, and cloud-based operation.
Therefore, no automatic association of the connector with your WMS is established, and no documented one-time processing is performed. For your integration, describe which message triggers a physical acceptance, which conveys a quality status, and which initiates a credit note. The keys should clearly reference the respective business process.
Evaluate as a standalone testing recommendation the occurrence of duplicate feedbacks, missing confirmations, unknown customers, and swapped status values. Following error correction, it must be clearly established which booking was effectively executed. Re-sending must not uncontrolledly increase quantity or availability. Compare the distribution by customer, product, batch, and status; a simple sum comparison alone may overlook assignment errors.
7. Example: Return matrix with two customers
The following example serves as a planning reference; it was not executed in pLG WMS. Customer A has 120 usable packages, while Customer B has 80. For Customer A, 24 packages are returned. These are initially fully tracked as return batches under evaluation. A credit adjustment does not alter the physical quantity.
For the subsequent inspection step, it is explicitly assumed that a competent technical assessment authorizes the re-use of 14 cartons. Six are rejected, four remain unresolved. The numbers do not substitute for a return evaluation. In particular, the decision cannot be derived solely from the quantity or from an externally intact carton.
| Test step | Physically A / B | Available for new orders A / B | Expectation or intentional error |
|---|---|---|---|
| Before recycle | 120 / 80 | 120 / 80 | 200 packages in total |
| Return A: 24 recorded | 144 / 80 | 120 / 80 | 224 physical; 24 backflows still not available |
| Disposition decision: 14 / 6 / 4 | 144 / 80 | 134 / 80 | 14 + 6 + 4 = 24; 10 remain unavailable |
| Credit note processed | 144 / 80 | 134 / 80 | Financial closing does not alter these quantities. |
| Duplicate acceptance message | 144 / 80 expected | 134 / 80 expected | An additional 24 resulted in 248 instead of 224 in total. |
| False Mandant | 120 / 104 would be incorrect | 120 / 80 initially | Total sum remains 224, but assignment is still incorrect. |
| Closure before stock issue or dispatch | 144 / 80 | 134 / 80 | 224 physical; 214 available; 10 not available |
8. Return history and migration must enable decisions to be clearly understood
For a subsequent review, "return closed" is often insufficient. Ensure that the incoming information, the original shipment involved, missing data points, and the decision made are clearly documented and retained. Change records and linked documents must remain understandable for the intended use.
Determine which events should be risk-basedly evaluated: changes to the client, re-approval, corrected batches, unexplained quantities, and privileged interventions may be particularly relevant. A movement overview is not automatically a complete audit trail. The extent of coverage and appropriate controls must be specifically verified.
During a cutover or migration, open trailing balances require special attention. Beyond merely transferring balance figures, attention must also be given to the significance of data states and the associated decision-making requirements. A dataset marked "reviewed" must not be interpreted as "available" following migration. Select appropriate comparison and error cases based on risk and data structure; a universal sample size would be inappropriate for this purpose.
9. Planning for involvement and effort of SMEs at transition points
The effort increases with product lines, customers, return pathways, and integrated systems. Particularly significant are inconsistent master data, inconsistent quality statuses, and manual exception routes. A new interface may require more coordination than the actual return form itself.
Storage and customer service provide the actual return flow; the responsible quality function determines the business decision-making requirements. IT and providers clarify data model, interfaces, roles and operation. In case of outsourced storage, responsibilities and communication paths between client and service provider belong to this. Manufacturer documents are usable after their real coverage, not completely or worthless.
Plan also for system failure: How are incoming packages identified and segregated when the WMS is unavailable? Who ensures no duplicate entry occurs upon system restart? Changes to the return flow dialogue, customer assignment, connector mapping, or automated inventory reconciliation require a documented impact assessment and appropriate validation evidence. Simple version numbers provide insufficient insight.
10. Checklist for traceable pLG usage
Use the following work aid prior to productive deployment and for significant changes. Critical is the presence of linked documentation verifying your actual configuration. Open questions regarding usage decisions must not be obfuscated by a technically successful interface test.
- Product line, build, modules, hosting, and responsibilities are clearly defined.
- GMP manufacturing process, GDP distribution, and commercial workflow are appropriately delineated.
- Tenant, item, batch, quantity and status identify the posting unambiguously.
- Return, storage, credit note, and restock availability have separate criteria.
- Roles and mobile execution paths are evaluated for permitted and non-permitted actions.
- Duplicate reports, missing receipts, and incorrect clients have been evaluated either through testing or risk-based justification.
- Reports and exports include the required assignment and decision history.
- Migration, normal operation, restart, and changes are considered in the usage decision.
Project experience and collaboration
Trace the return, client account and stock availability separately
With warehouse operations, QA and IT, we test a return involving similarly named stock held for two clients. We trace receipt, return to storage, the credit note and the decision on available quantity separately. Negative tests can demonstrate that an existing separation works. Where the return wrongly affects availability, the implementation partner needs to adjust the configuration. We also check what happens when the same confirmation arrives twice. A credit note does not authorise pharmaceutical release.
Frequently asked questions about proLogistik pLG WMS
Are pLG WMS and DILOS merely different names for the same software?
This is not generally substantiated based on public information. The group side describes the inherited DILOS business unit and specifically references the system separately. Other product lines are also presented separately. Review your contract and installation documentation prior to transferring functional specifications or existing test results. A shared vendor environment does not automatically imply identical data models, roles, or interfaces.
Does the medicinal product sales website apply to each pLG installation?
No. It explicitly describes pLG WMS-TM3 as a specific e-commerce variant. The ABDA-, ADAS-, or MSV3 functions mentioned therein must not be assumed as part of the standard scope of your general pLG WMS without proper evaluation. Furthermore, pharmaceutical trade must be distinguished from GMP-manufacturing. Therefore, confirm the product line, booked modules, and actual processes prior to deriving any validation requirements or tests.
Does the IML testing already establish our GxP suitability?
The manufacturer's site assigns the IML check to the Warehouse Logistics provider portal. It does not replace any proof of your GxP-relevant configuration. The actual available documents and their scope are evaluable. For your return logic, for example, master data, decision-making powers, interfaces and operational procedures remain to be considered. A general vendor review does not answer these customer-specific questions automatically.
When may a returned batch verified in the WMS be made available again?
Only when the professional assessment and decision relevant to the intended use are available. A technical classification or re-stocking alone is insufficient. In the GMP manufacturing context, Chapter 5.70 is particularly relevant; in the wholesale trade, specific GDP return conditions apply. The Warehouse Management System must accurately implement the approved effect. The authority to decide and the required documentation must be defined within the appropriate process.
Why is it insufficient to reconcile the total inventory levels between ERP and WMS?
A correct sum can mask incorrect assignments. In the example of this article, 24 packages assigned to the wrong owner still total 224 packages overall. Nevertheless, the data for owner, batch, and usage decision would remain inaccurate. Therefore, compare the professionally relevant subsets including status and unit of measure. Use intentionally similar test data to ensure the test reveals realistic instances of misassignment.
Can a credit note automatically re-release the goods?
Whether integration produces this effect must be verified for your specific configuration. From a technical standpoint, a credit adjustment initially represents a commercial correction and does not substitute for a quality decision. Therefore, an automatic linkage must not be assumed or implemented without proper evaluation. Clearly define triggers, prerequisites, and responsible parties, and test a scenario involving a completed credit adjustment but still unresolved return.
Is the Supply Chain Connector an automatic component of pLG WMS?
The public offering describes it as a named solution for data exchange and format conversion. Whether it is implemented at your site depends on the contract and system architecture. The support of a specific format does not constitute valid functional alignment. Inquire about mapping, error handling, monitoring, and retry mechanisms. The public documentation does not provide evidence for a fixed retry sequence or automated prevention of duplicate entries.
How do we verify the loss of confirmation for a return booking?
First, determine whether the acceptance in the target system has already been booked. Then, in the controlled test, retransmit the message or reprocess the intended error scenario and assess the impact. In the as-designed example, there remain 24 backflows, not 48. Include customer, batch, and availability factors. This constitutes a separate review recommendation. Clarify with the vendor whether your pLG configuration is capable of detecting duplicates, and verify this at the actual site.
Must we establish completely separate user accounts for each client?
Not mandatory. Annex 11 does not prescribe a fixed allocation of "one account per client." The access setup must align with assigned tasks, required visibility, and authorization levels. Verify that cross-client activities are feasible and that unauthorized modifications are minimized. Individual accounts must enable appropriate traceability of actions. Additional considerations include exports, mobile devices, representatives, and privileged interventions; visible client selection alone is insufficient.
What should occur prior to a pLG release with open returns?
For each relevant state, specify whether it is closed, migrated, or controlled and continued in the legacy system. The volumes must remain linked to their professional meaning and supported by adequate documentation. Pay particular attention to partially assessed backflows and differing customer and status codes. The selected retention approach must enable the intended access. A simple inventory transfer without a decision context may be insufficient.
Sources and review date
Source date: 6 October 2026. Current public information identifies pLG WMS and specific product lines such as WMS-TM3; a numerical software release version is not substantiated. DILOS, LOGIS MOVE, and Logistar are not to be considered equivalent in a technical sense. Manufacturer websites and brochures do not constitute a description of the installed system configuration. Human medicinal product GMP and GDP requirements are applied separately depending on the specific process.
- proLogistik, pLG Warehouse Management System
- proLogistik Group: Company and Product Assignment
- proLogistik, pLG WMS feature overview
- proLogistik, Warehouse Management System – 3PL
- proLogistik, returns management with pLG WMS
- proLogistik, pLG Supply Chain Connector
- proLogistik, pLG WMS-TM3 in pharmaceutical distribution
- proLogistik, digital stocktaking with pLG WMS
- European Commission: EudraLex Volume 4
- EU GMP Annex 11: Computerised Systems, January 2011 revision
- EU GMP Chapter 4: Documentation, January 2011
- EU GMP Chapter 5: Production, Revision 2014/2015
- European Commission: GDP Guidelines for Human Medicinal Products
Sources checked: .
Securing returns and inventory decisions
We support you in defining the scope of your pLG usage and providing specific evidence for returns, clients, and interfaces.
- Computer system validation →
Bring your GxP systems into validated operation, from laboratory software, MES and eQMS to ERP. We define the scope, plan risk-based tests using GAMP 5 and hand the evidence to QA for release.

